Related Experiment Video
Updated: Jun 29, 2026

10:27
Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
Published on: July 25, 2020
7.8K
DMX-200 in Patients With Primary Focal Segmental Glomerulosclerosis: Results of the Phase 2 ACTION2 Trial
Hiddo J L Heerspink1, Alessia Fornoni2, Lesley A Inker3
1Department of Clinical Pharmacy and Pharmacology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
Kidney International Reports
|December 22, 2025
Abstract
No abstract available in PubMed .

